Search

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Cataract care at Staffordshire eye hospital rated ‘outstanding’ by Care Quality Commission

SpaMedica in Newcastle-under-Lyme has been awarded the highest possible rating following a recent inspection by the Care Quality Commission (CQC), the independent regulator of health and social care in England.

Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium

Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.

Return to Lviv

The ‘Return to Lviv’ trip saw Wesley McLoughlin and Doireann Hughes journey for 10 days over more than 4000 miles, via land, air and sea to deliver ophthalmic aid to Ukraine.

Partially sighted poet focuses on visual impairment and parenthood in new book

Glasgow-based poet Nuala Watt (39) aims to show that disabled people “have important things to say” in her latest book of poems, ‘The Department of Work and Pensions Assesses a Jade Fish’.

Blind veterans take to the hills for life-changing winter survival course

A group of inspirational Sight Scotland Veterans recently ventured up the Cairngorms to participate in a life-changing Winter Skills Course.

Dumfries and Galloway teen thrives as volunteer after sight loss

At just 18, Finlay Anderson has already achieved so much. Preparing to embark on a new academic journey at the University of Edinburgh to study Law, Finlay’s path has been paved with dedication to advocacy and volunteerism, which he began navigating from a young age after losing his sight.

Vision for the future: Changes to Glaucoma UK’s research programme in 2025

Glaucoma UK is excited to announce a new, reshaped Research Grants Programme for 2025. Set to open in January, this programme aims to support innovative research to improve the understanding, treatment, and care of glaucoma. Alongside opportunities for researchers at...

Minister visits London special school to see SeeAbility eyecare team in action

Last month, disability charity SeeAbility had a special visitor to a very special school: Minister for Care, Stephen Kinnock MP. Stephen visited The Village School in London to see children receiving eye care from SeeAbility’s specialist team. He also got...

Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...

New genomic test saves Moorfields patient’s sight

Moorfields patient Ellie Irwin’s stubborn and debilitating eye inflammation was successfully treated as a result of a new metagenomic service identifying the cause of this as a rare infection. In 2019, Ellie first got symptoms of uveitis, a condition characterised...